TAIM
PRAH

TD Ameritrade Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

TD Ameritrade Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2
Closed – – 676
2019
Q3 		$0 Buy
+2
New +$199 ﹤0.01% 741
2018
Q4 		– Sell
-76
Closed -$8K – 626
2018
Q3 		$8K Buy
+76
New +$7.91K ﹤0.01% 357

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

TD Ameritrade Investment Management's PRAH Position: Q4 2019 in Review

TD Ameritrade Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 2 shares.

TD Ameritrade Investment Management first reported a position in PRAH in Q3 2018 and held it in 2 quarters. The position peaked at $8K in Q3 2018. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • TD Ameritrade Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 2 PRA Health Sciences, Inc. shares in Q4 2019.
  • TD Ameritrade Investment Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 2 quarters.
  • TD Ameritrade Investment Management's PRA Health Sciences, Inc. position peaked at $8K in Q3 2018.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on TD Ameritrade Investment Management's 13F filing for Q4 2019, filed 7 Feb 2020.